Buck Wealth Strategies’s Gilead Sciences GILD Stock Holding History

Buck Wealth Strategies’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54.2K	Buy	+429	New	+$56.5K	0.01%	337

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Buck Wealth Strategies's GILD Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in Gilead Sciences (GILD) in Q2 2026: 429 shares worth $54.2K. The stake represents 0.01% of the portfolio and ranks #337 among its holdings.

1,476 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Buck Wealth Strategies held 429 shares of Gilead Sciences worth $54.2K as of Q2 2026.
Gilead Sciences was a new Buck Wealth Strategies position in Q2 2026.
Gilead Sciences made up 0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #337 holding.
1,476 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.